
<HTML>
<HEAD>
</HEAD>
<BODY BGCOLOR="#FFFFFF" LINK=BLUE  VLINK=PURPLE>
<BR>
<FONT SIZE=3 ><A HREF="#04BOS2368_1">QuickLinks</A></FONT>
<font size=3> -- Click here to rapidly navigate through this document</font>

<P><FONT SIZE=2>
<hr noshade width=100% align=left size=4>
<hr noshade width=100% align=left size=1> </FONT></P>

<P ALIGN="CENTER"><FONT SIZE=5><B>UNITED STATES<BR>
SECURITIES AND EXCHANGE COMMISSION<BR>  </B></FONT><FONT SIZE=2><B>WASHINGTON, D.C. 20549  </B></FONT></P>

<P ALIGN="CENTER"><FONT SIZE=5><B>FORM 8-K  </B></FONT></P>

<P ALIGN="CENTER"><FONT SIZE=3><B>CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d)<BR>
OF THE SECURITIES EXCHANGE ACT OF 1934  </B></FONT></P>

<P ALIGN="CENTER"><FONT SIZE=2>DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): </FONT><FONT SIZE=2><B>December&nbsp;23, 2004  </B></FONT></P>

<P ALIGN="CENTER"><FONT SIZE=5><B>GENZYME CORPORATION<BR>  </B></FONT><FONT SIZE=2>(Exact name of registrant as specified in its charter) </FONT></P>

<!-- User-specified TAGGED TABLE -->
<TABLE WIDTH="100%" BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR VALIGN="TOP">
<TD WIDTH="32%" ALIGN="CENTER"><FONT SIZE=2><B>Massachusetts<BR> </B></FONT><FONT SIZE=2>(State or other jurisdiction<BR>
of incorporation or organization)</FONT></TD>
<TD WIDTH="1%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="32%" ALIGN="CENTER"><FONT SIZE=2><B>0-14680<BR> </B></FONT><FONT SIZE=2>(Commission<BR>
File Number)</FONT></TD>
<TD WIDTH="1%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="32%" ALIGN="CENTER"><FONT SIZE=2><B>06-1047163<BR> </B></FONT><FONT SIZE=2>(IRS Employer<BR>
Identification Number)</FONT></TD>
</TR>
</TABLE>
<!-- end of user-specified TAGGED TABLE -->

<P ALIGN="CENTER"><FONT SIZE=2><B>500 Kendall Street, Cambridge, Massachusetts 02142<BR>  </B></FONT><FONT SIZE=2>(Address of Principal Executive Offices)&nbsp;&nbsp;&nbsp;&nbsp;(Zip Code) </FONT></P>

<P ALIGN="CENTER"><FONT SIZE=2>Registrant's
telephone number, including area code: </FONT><FONT SIZE=2><B>(617)&nbsp;252-7500</B></FONT></P>

<P><FONT SIZE=2><hr
noshade width=100% align=left size=1>
<hr noshade width=100% align=left size=4> </FONT></P>

<HR NOSHADE>
<P style='page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=1,EFW="2148237",CP="GENZYME CORPORATION",DN="1",CHK=846278,FOLIO='blank',FILE='DISK012:[04BOS8.04BOS2368]BA2368A.;6',USER='TMCKINN',CD='23-DEC-2004;14:36' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->
<!-- TOC_END -->

<P><FONT SIZE=2><A
NAME="ca2368_item_8.01_other_events."> </A>
<A NAME="toc_ca2368_1"> </A>
<BR></FONT><FONT SIZE=2><B>Item 8.01 Other Events.    <BR>    </B></FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As we reported on our current report on Form&nbsp;8-K dated December&nbsp;20, 2004 and filed with the SEC on December&nbsp;21, 2004, on
December&nbsp;20, 2004, we completed the acquisition of ILEX Oncology,&nbsp;Inc., a publicly held Delaware corporation, pursuant to the terms of an Agreement and Plan of Merger dated as of
February&nbsp;26, 2004 among us, two of our wholly-owned subsidiaries (GLBC Corp. and GLBC LLC), and ILEX. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We
are filing this report to include the unaudited, pro forma combined financial information which describes the pro forma effect of our transaction with ILEX on our statements of
operations for the year ended December&nbsp;31, 2003 and the nine months ended September&nbsp;30, 2004, as if the transaction had occurred on January&nbsp;1, 2003, and our balance sheet as of
September&nbsp;30, 2004, as if the transaction had occurred on this date. </FONT></P>

<P><FONT SIZE=2><A
NAME="ca2368_item_9.01._financial_statements_and_exhibits."> </A>
<A NAME="toc_ca2368_2"> </A>
<BR></FONT><FONT SIZE=2><B>Item 9.01. Financial Statements and Exhibits.    <BR>    </B></FONT></P>

<DL compact>
<DT style='margin-bottom:-11pt;'><FONT SIZE=2>(c)</FONT></DT><DD><FONT SIZE=2>Exhibits:
</FONT></DD></DL>
<BR>

<!-- User-specified TAGGED TABLE -->
<TABLE WIDTH="78%" BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR VALIGN="TOP">
<TD WIDTH="6%" ALIGN="RIGHT"><FONT SIZE=2>99.1</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="92%"><FONT SIZE=2>Unaudited, pro forma combined financial information which describes the pro forma effect of our transaction with ILEX on our statements of operations for the year ended December&nbsp;31, 2003 and the nine months ended
September&nbsp;30, 2004, as if the transaction had occurred on January&nbsp;1, 2003, and our balance sheet as of September&nbsp;30, 2004, as if the transaction had occurred on this date. Filed herewith.</FONT></TD>
</TR>
</TABLE>
<!-- end of user-specified TAGGED TABLE -->

<HR NOSHADE>
<P style='page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=2,EFW="2148237",CP="GENZYME CORPORATION",DN="1",CHK=851279,FOLIO='blank',FILE='DISK012:[04BOS8.04BOS2368]CA2368A.;6',USER='CJOHNSOC',CD='22-DEC-2004;14:55' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->
<!-- TOC_END -->
<P ALIGN="CENTER"><FONT SIZE=2><A
NAME="ja2368_signature"> </A>
<A NAME="toc_ja2368_1"> </A>
<BR></FONT><FONT SIZE=2><B>SIGNATURE    <BR>    </B></FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized. </FONT></P>

<!-- User-specified TAGGED TABLE -->
<TABLE WIDTH="100%" BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR VALIGN="TOP">
<TD WIDTH="39%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD COLSPAN=2><FONT SIZE=2>GENZYME CORPORATION</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="39%"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD WIDTH="4%"><FONT SIZE=2><BR>
By:</FONT></TD>
<TD WIDTH="54%"><FONT SIZE=2><BR>
/s/&nbsp;&nbsp;</FONT><FONT SIZE=2>MICHAEL S. WYZGA</FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><HR NOSHADE><FONT SIZE=2> Michael S. Wyzga<BR></FONT> <FONT SIZE=2><I>Executive Vice President, Finance, Chief Financial Officer, and
Chief Accounting Officer </I></FONT></TD>
</TR>
</TABLE>
<!-- end of user-specified TAGGED TABLE -->


<P><FONT SIZE=2>DATE:
December 23, 2004 </FONT></P>

<HR NOSHADE>
<P style='page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=3,EFW="2148237",CP="GENZYME CORPORATION",DN="1",CHK=932901,FOLIO='blank',FILE='DISK012:[04BOS8.04BOS2368]JA2368A.;6',USER='TMCKINN',CD='23-DEC-2004;14:37' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->
<!-- TOC_END -->
<P ALIGN="CENTER"><FONT SIZE=2><A
NAME="ka2368_exhibit_index"> </A>
<A NAME="toc_ka2368_1"> </A>
<BR></FONT><FONT SIZE=2><B>EXHIBIT INDEX    <BR>    </B></FONT></P>

<!-- User-specified TAGGED TABLE -->
<TABLE WIDTH="80%" BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR VALIGN="BOTTOM">
<TH WIDTH="11%" ALIGN="CENTER"><FONT SIZE=1><B>EXHIBIT<BR>
NO.</B></FONT><HR NOSHADE></TH>
<TH WIDTH="3%"><FONT SIZE=1>&nbsp;</FONT></TH>
<TH WIDTH="86%" ALIGN="LEFT"><FONT SIZE=1><B>DESCRIPTION<BR> </B></FONT><HR NOSHADE></TH>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="11%" ALIGN="RIGHT"><FONT SIZE=2>99.1</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="86%"><FONT SIZE=2>Unaudited, pro forma combined financial information which describes the pro forma effect of our transaction with ILEX on our statements of operations for the year ended December&nbsp;31, 2003 and the nine months ended
September&nbsp;30, 2004, as if the transaction had occurred on January&nbsp;1, 2003, and our balance sheet as of September&nbsp;30, 2004, as if the transaction had occurred on this date. Filed herewith.</FONT></TD>
</TR>
</TABLE>
<!-- end of user-specified TAGGED TABLE -->

<HR NOSHADE>
<P style='page-break-before:always'></p>
<!-- ZEQ.=1,SEQ=4,EFW="2148237",CP="GENZYME CORPORATION",DN="1",CHK=42076,FOLIO='blank',FILE='DISK012:[04BOS8.04BOS2368]KA2368A.;5',USER='CJOHNSOC',CD='22-DEC-2004;14:55' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->
<BR>
<P><br><A NAME="04BOS2368_1">QuickLinks</A><br></P><!-- TOC_BEGIN -->
<UL>
<FONT SIZE=2><A HREF="#toc_ca2368_1">Item 8.01 Other Events.</A></FONT><BR>
<FONT SIZE=2><A HREF="#toc_ca2368_2">Item 9.01. Financial Statements and Exhibits.</A></FONT><BR>
</UL>
<!-- TOC_BEGIN -->
<FONT SIZE=2><A HREF="#toc_ja2368_1">SIGNATURE</A></FONT><BR>
<!-- TOC_BEGIN -->
<FONT SIZE=2><A HREF="#toc_ka2368_1">EXHIBIT INDEX</A></FONT><BR>
<!-- SEQ=,FILE='QUICKLINK',USER=CJOHNSOC,SEQ=,EFW="2148237",CP="GENZYME CORPORATION",DN="1" -->
<!-- TOCEXISTFLAG -->
</BODY>
</HTML>

